APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vascular Endothelial Growth Factor B

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vascular Endothelial Growth Factor B Industry Growth and Trends Forecast to 2032

22 December 202595 pages

Choose your research edition.

Industry ResearchVascular Endothelial Growth Factor B Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Endothelial Growth Factor B Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Vascular Endothelial Growth Factor B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Endothelial Growth Factor B Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Endothelial Growth Factor B Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vascular Endothelial Growth Factor B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vascular Endothelial Growth Factor B is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vascular Endothelial Growth Factor B is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vascular Endothelial Growth Factor B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vascular Endothelial Growth Factor B include Eli Lilly and Company, Regeneron Pharmaceuticals Inc, Formycon AG, CSL Ltd and Alteogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vascular Endothelial Growth Factor B market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vascular Endothelial Growth Factor B market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vascular Endothelial Growth Factor B market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vascular Endothelial Growth Factor B.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vascular Endothelial Growth Factor B market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vascular Endothelial Growth Factor B Market by Company

Eli Lilly and Company

Regeneron Pharmaceuticals Inc

Formycon AG

CSL Ltd

Alteogen Inc

Vascular Endothelial Growth Factor B Segment by Type

CSL-346

Aflibercept

Aflibercept Biosimilar

Others

Vascular Endothelial Growth Factor B Segment by Application

Rectal Cancer

Diabetic Nephropathy

Retinal Vein Occlusion

Others

Vascular Endothelial Growth Factor B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Endothelial Growth Factor B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Endothelial Growth Factor B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Endothelial Growth Factor B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vascular Endothelial Growth Factor B manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vascular Endothelial Growth Factor B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CSL-346 Table 2. Major Company of Aflibercept Table 3. Major Company of Aflibercept Biosimilar Table 4. Major Company of Others Table 5. Global Vascular Endothelial Growth Factor B Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 7. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type (2021-2026) Table 8. Global Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (US$ Million) Table 9. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Type (2021-2026) Table 10. Global Vascular Endothelial Growth Factor B Price by Type (2021-2026) & (US$/unit) Table 11. Global Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 12. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type (2027-2032) Table 13. Global Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (US$ Million) Table 14. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Type (2027-2032) Table 15. Global Vascular Endothelial Growth Factor B Price by Type (2027-2032) & (US$/unit) Table 16. North America Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 17. North America Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 19. Europe Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 23. Latin America Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (US$ Million) Table 26. Vascular Endothelial Growth Factor B Industry Trends Table 27. Vascular Endothelial Growth Factor B Industry Drivers Table 28. Vascular Endothelial Growth Factor B Industry Opportunities and Challenges Table 29. Vascular Endothelial Growth Factor B Industry Restraints Table 30. Global Vascular Endothelial Growth Factor B Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company (2021-2026) Table 32. Global Vascular Endothelial Growth Factor B Sales by Company (2021-2026) & (k units) Table 33. Global Vascular Endothelial Growth Factor B Sales Share by Company (2021-2026) Table 34. Global Vascular Endothelial Growth Factor B Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Vascular Endothelial Growth Factor B Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Vascular Endothelial Growth Factor B Major Company Production Sites and Headquarters Table 37. Global Vascular Endothelial Growth Factor B Company, Product Type & Application Table 38. Global Vascular Endothelial Growth Factor B Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Vascular Endothelial Growth Factor B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Vascular Endothelial Growth Factor B Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Vascular Endothelial Growth Factor B Sales by Region (2021-2026) & (k units) Table 43. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Region (2021-2026) Table 44. Global Vascular Endothelial Growth Factor B Sales by Region (2021-2026) & (US$ Million) Table 45. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Region (2021-2026) Table 46. Global Vascular Endothelial Growth Factor B Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Vascular Endothelial Growth Factor B Sales by Region (2027-2032) & (k units) Table 48. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Region (2027-2032) Table 49. Global Vascular Endothelial Growth Factor B Sales by Region (2027-2032) & (US$ Million) Table 50. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Region (2027-2032) Table 51. Global Vascular Endothelial Growth Factor B Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Vascular Endothelial Growth Factor B Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 54. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application (2021-2026) Table 55. Global Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (US$ Million) Table 56. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Application (2021-2026) Table 57. Global Vascular Endothelial Growth Factor B Price by Application (2021-2026) & (US$/unit) Table 58. Global Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 59. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application (2027-2032) Table 60. Global Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (US$ Million) Table 61. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Application (2027-2032) Table 62. Global Vascular Endothelial Growth Factor B Price by Application (2027-2032) & (US$/unit) Table 63. North America Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 64. North America Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 66. Europe Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 70. Latin America Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (US$ Million) Table 73. Eli Lilly and Company Company Information Table 74. Eli Lilly and Company Business Overview Table 75. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio Table 77. Eli Lilly and Company Recent Development Table 78. Regeneron Pharmaceuticals Inc Company Information Table 79. Regeneron Pharmaceuticals Inc Business Overview Table 80. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio Table 82. Regeneron Pharmaceuticals Inc Recent Development Table 83. Formycon AG Company Information Table 84. Formycon AG Business Overview Table 85. Formycon AG Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Formycon AG Vascular Endothelial Growth Factor B Product Portfolio Table 87. Formycon AG Recent Development Table 88. CSL Ltd Company Information Table 89. CSL Ltd Business Overview Table 90. CSL Ltd Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio Table 92. CSL Ltd Recent Development Table 93. Alteogen Inc Company Information Table 94. Alteogen Inc Business Overview Table 95. Alteogen Inc Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio Table 97. Alteogen Inc Recent Development Table 98. North America Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 99. North America Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 100. North America Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2026) Table 101. North America Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032) & (k units) Table 102. North America Vascular Endothelial Growth Factor B Sales Market Share Forecast by Country (2027-2032) Table 103. North America Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Vascular Endothelial Growth Factor B Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Vascular Endothelial Growth Factor B Market Share by Country (2021-2026) Table 106. North America Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Vascular Endothelial Growth Factor B Market Share Forecast by Country (2027-2032) Table 108. Europe Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 109. Europe Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 110. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2026) Table 111. Europe Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032) & (k units) Table 112. Europe Vascular Endothelial Growth Factor B Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Vascular Endothelial Growth Factor B Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Vascular Endothelial Growth Factor B Market Share by Country (2021-2026) Table 116. Europe Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Vascular Endothelial Growth Factor B Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 120. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032) & (k units) Table 122. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Vascular Endothelial Growth Factor B Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Vascular Endothelial Growth Factor B Market Share by Country (2021-2026) Table 126. Asia-Pacific Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Vascular Endothelial Growth Factor B Market Share Forecast by Country (2027-2032) Table 128. Latin America Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Latin America Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 130. Latin America Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2026) Table 131. Latin America Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032) & (k units) Table 132. Latin America Vascular Endothelial Growth Factor B Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Vascular Endothelial Growth Factor B Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Vascular Endothelial Growth Factor B Market Share by Country (2021-2026) Table 136. Latin America Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Vascular Endothelial Growth Factor B Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 140. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032) & (k units) Table 142. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Vascular Endothelial Growth Factor B Market Share by Country (2021-2026) Table 146. Middle East and Africa Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Vascular Endothelial Growth Factor B Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Vascular Endothelial Growth Factor B Distributors List Table 151. Vascular Endothelial Growth Factor B Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Vascular Endothelial Growth Factor B Image Figure 2. Global Vascular Endothelial Growth Factor B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vascular Endothelial Growth Factor B Market Size (2021-2032) & (US$ Million) Figure 4. Global Vascular Endothelial Growth Factor B Sales (2021-2032) & (k units) Figure 5. CSL-346 Image Figure 6. Global CSL-346 Sales YoY Growth (2021-2032) & (k units) Figure 7. Aflibercept Image Figure 8. Global Aflibercept Sales YoY Growth (2021-2032) & (k units) Figure 9. Aflibercept Biosimilar Image Figure 10. Global Aflibercept Biosimilar Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Vascular Endothelial Growth Factor B Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Vascular Endothelial Growth Factor B Market Share by Type 2025 VS 2032 Figure 15. North America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2025 Figure 16. North America Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2025 Figure 17. Europe Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2025 Figure 18. Europe Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2025 Figure 21. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Vascular Endothelial Growth Factor B Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Rectal Cancer Image Figure 28. Global Rectal Cancer Sales YoY Growth (2021-2032) & (k units) Figure 29. Diabetic Nephropathy Image Figure 30. Global Diabetic Nephropathy Sales YoY Growth (2021-2032) & (k units) Figure 31. Retinal Vein Occlusion Image Figure 32. Global Retinal Vein Occlusion Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Vascular Endothelial Growth Factor B Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Vascular Endothelial Growth Factor B Market Share by Application 2025 VS 2032 Figure 37. North America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2025 Figure 38. North America Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2025 Figure 39. Europe Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2025 Figure 40. Europe Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2025 Figure 43. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2025 Figure 47. North America Vascular Endothelial Growth Factor B Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Vascular Endothelial Growth Factor B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Vascular Endothelial Growth Factor B Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Vascular Endothelial Growth Factor B Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Vascular Endothelial Growth Factor B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Vascular Endothelial Growth Factor B Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Vascular Endothelial Growth Factor B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Vascular Endothelial Growth Factor B Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Vascular Endothelial Growth Factor B Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Vascular Endothelial Growth Factor B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Vascular Endothelial Growth Factor B Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Vascular Endothelial Growth Factor B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Vascular Endothelial Growth Factor B Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Vascular Endothelial Growth Factor B Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Vascular Endothelial Growth Factor B Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • CSL-346
  • Aflibercept
  • Aflibercept Biosimilar
  • Others
Applications
  • Rectal Cancer
  • Diabetic Nephropathy
  • Retinal Vein Occlusion
  • Others
Companies covered
  • Eli Lilly and Company
  • Regeneron Pharmaceuticals Inc
  • Formycon AG
  • CSL Ltd
  • Alteogen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vascular Endothelial Growth Factor B Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vascular Endothelial Growth Factor B Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vascular Endothelial Growth Factor B Market by Type
  6. 1.3.1 CSL-346
  7. 1.3.2 Aflibercept
  8. 1.3.3 Aflibercept Biosimilar
  9. 1.3.4 Others
  10. 1.4 Global Vascular Endothelial Growth Factor B Market Size by Type
  11. 1.4.1 Global Vascular Endothelial Growth Factor B Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Vascular Endothelial Growth Factor B Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Vascular Endothelial Growth Factor B Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Vascular Endothelial Growth Factor B Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Vascular Endothelial Growth Factor B Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Vascular Endothelial Growth Factor B Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Vascular Endothelial Growth Factor B Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Vascular Endothelial Growth Factor B Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vascular Endothelial Growth Factor B Industry Trends
  2. 2.2 Vascular Endothelial Growth Factor B Industry Drivers
  3. 2.3 Vascular Endothelial Growth Factor B Industry Opportunities and Challenges
  4. 2.4 Vascular Endothelial Growth Factor B Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vascular Endothelial Growth Factor B Revenue (2021-2026)
  2. 3.2 Global Top Players by Vascular Endothelial Growth Factor B Sales (2021-2026)
  3. 3.3 Global Top Players by Vascular Endothelial Growth Factor B Price (2021-2026)
  4. 3.4 Global Vascular Endothelial Growth Factor B Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vascular Endothelial Growth Factor B Major Company Production Sites & Headquarters
  6. 3.6 Global Vascular Endothelial Growth Factor B Company, Product Type & Application
  7. 3.7 Global Vascular Endothelial Growth Factor B Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vascular Endothelial Growth Factor B Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vascular Endothelial Growth Factor B Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vascular Endothelial Growth Factor B Tier 1, Tier 2, and Tier 3
4 Vascular Endothelial Growth Factor B Regional Status and Outlook
  1. 4.1 Global Vascular Endothelial Growth Factor B Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vascular Endothelial Growth Factor B Historic Market Size by Region
  3. 4.2.1 Global Vascular Endothelial Growth Factor B Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vascular Endothelial Growth Factor B Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vascular Endothelial Growth Factor B Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vascular Endothelial Growth Factor B Forecasted Market Size by Region
  7. 4.3.1 Global Vascular Endothelial Growth Factor B Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vascular Endothelial Growth Factor B Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vascular Endothelial Growth Factor B Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vascular Endothelial Growth Factor B by Application
  1. 5.1 Vascular Endothelial Growth Factor B Market by Application
  2. 5.1.1 Rectal Cancer
  3. 5.1.2 Diabetic Nephropathy
  4. 5.1.3 Retinal Vein Occlusion
  5. 5.1.4 Others
  6. 5.2 Global Vascular Endothelial Growth Factor B Market Size by Application
  7. 5.2.1 Global Vascular Endothelial Growth Factor B Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Vascular Endothelial Growth Factor B Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Vascular Endothelial Growth Factor B Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Vascular Endothelial Growth Factor B Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Vascular Endothelial Growth Factor B Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Vascular Endothelial Growth Factor B Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Vascular Endothelial Growth Factor B Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Vascular Endothelial Growth Factor B Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly and Company
  2. 6.1.1 Eli Lilly and Company Company Information
  3. 6.1.2 Eli Lilly and Company Business Overview
  4. 6.1.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio
  6. 6.1.5 Eli Lilly and Company Recent Developments
  7. 6.2 Regeneron Pharmaceuticals Inc
  8. 6.2.1 Regeneron Pharmaceuticals Inc Company Information
  9. 6.2.2 Regeneron Pharmaceuticals Inc Business Overview
  10. 6.2.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio
  12. 6.2.5 Regeneron Pharmaceuticals Inc Recent Developments
  13. 6.3 Formycon AG
  14. 6.3.1 Formycon AG Company Information
  15. 6.3.2 Formycon AG Business Overview
  16. 6.3.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Formycon AG Vascular Endothelial Growth Factor B Product Portfolio
  18. 6.3.5 Formycon AG Recent Developments
  19. 6.4 CSL Ltd
  20. 6.4.1 CSL Ltd Company Information
  21. 6.4.2 CSL Ltd Business Overview
  22. 6.4.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio
  24. 6.4.5 CSL Ltd Recent Developments
  25. 6.5 Alteogen Inc
  26. 6.5.1 Alteogen Inc Company Information
  27. 6.5.2 Alteogen Inc Business Overview
  28. 6.5.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio
  30. 6.5.5 Alteogen Inc Recent Developments
7 North America by Country
  1. 7.1 North America Vascular Endothelial Growth Factor B Sales by Country
  2. 7.1.1 North America Vascular Endothelial Growth Factor B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vascular Endothelial Growth Factor B Sales by Country (2021-2026)
  4. 7.1.3 North America Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vascular Endothelial Growth Factor B Market Size by Country
  6. 7.2.1 North America Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vascular Endothelial Growth Factor B Market Size by Country (2021-2026)
  8. 7.2.3 North America Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vascular Endothelial Growth Factor B Sales by Country
  2. 8.1.1 Europe Vascular Endothelial Growth Factor B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vascular Endothelial Growth Factor B Sales by Country (2021-2026)
  4. 8.1.3 Europe Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vascular Endothelial Growth Factor B Market Size by Country
  6. 8.2.1 Europe Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vascular Endothelial Growth Factor B Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vascular Endothelial Growth Factor B Sales by Country
  2. 9.1.1 Asia-Pacific Vascular Endothelial Growth Factor B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vascular Endothelial Growth Factor B Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vascular Endothelial Growth Factor B Market Size by Country
  6. 9.2.1 Asia-Pacific Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vascular Endothelial Growth Factor B Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vascular Endothelial Growth Factor B Sales by Country
  2. 10.1.1 South America Vascular Endothelial Growth Factor B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vascular Endothelial Growth Factor B Sales by Country (2021-2026)
  4. 10.1.3 South America Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vascular Endothelial Growth Factor B Market Size by Country
  6. 10.2.1 South America Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vascular Endothelial Growth Factor B Market Size by Country (2021-2026)
  8. 10.2.3 South America Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country
  2. 11.1.1 Middle East and Africa Vascular Endothelial Growth Factor B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vascular Endothelial Growth Factor B Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Country
  6. 11.2.1 Middle East and Africa Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vascular Endothelial Growth Factor B Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vascular Endothelial Growth Factor B Value Chain Analysis
  2. 12.1.1 Vascular Endothelial Growth Factor B Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vascular Endothelial Growth Factor B Production Mode & Process
  7. 12.2 Vascular Endothelial Growth Factor B Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vascular Endothelial Growth Factor B Distributors
  10. 12.2.3 Vascular Endothelial Growth Factor B Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst